Â¥
9.69
Sep 30
New Key Statistics Module, Z-Score and F-Score
SZSE:002923 Key Ratios
Market Cap ¥ M | 3,245.12 |
Enterprise Value ¥ M | 3,641.18 |
P/E(ttm) | 96.90 |
PE Ratio without NRI | 48.69 |
Forward PE Ratio | -- |
Price/Book | 2.83 |
Price/Sales | 2.68 |
Price/Free Cash Flow | 39.38 |
Price/Owner Earnings | -- |
Payout Ratio % | 1.01 |
Revenue (TTM) ¥ M | 1,233.00 |
EPS (TTM) ¥ | 0.10 |
Beneish M-Score | -2.88 |
10-y EBITDA Growth Rate % | 8.70 |
5-y EBITDA Growth Rate % | 8.60 |
y-y EBITDA Growth Rate % | -68.60 |
EV-to-EBIT | 54.47 |
EV-to-EBITDA | 54.47 |
PEG | 5.66 |
Shares Outstanding M | 334.89 |
Net Margin (%) | 2.87 |
Operating Margin % | 8.70 |
Pre-tax Margin (%) | 3.74 |
Quick Ratio | 0.88 |
Current Ratio | 1.99 |
ROA % (ttm) | 1.60 |
ROE % (ttm) | 3.01 |
ROIC % (ttm) | 4.75 |
Dividend Yield % | 2.06 |
Altman Z-Score | 3.01 |
SZSE:002923 Number of Guru Trades
SZSE:002923 Volume of Guru Trades
Gurus Latest Trades with SZSE:002923
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002923 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhuhai Rundu Pharmaceutical Co Ltd Insider Transactions
No Available Data